Literature DB >> 16885178

Oesophageal dysmotility in systemic sclerosis: comparison of HRCT and scintigraphy.

E H Pitrez1, M Bredemeier, R M Xavier, K G Capobianco, V G Restelli, M V Vieira, D H C Ludwig, J C T Brenol, A P A Furtado, L M B Fonseca, B Gutfilen.   

Abstract

The aim of this study was to compare oesophageal abnormalities observed in high-resolution CT with radionuclide transit in patients with systemic sclerosis. 76 patients with systemic sclerosis were evaluated by high-resolution CT and oesophageal transit scintigraphy. Residual activity > or =20% (in relation to peak activity) at 15 s after the beginning of the swallow of the labelled liquid (in supine position) was considered indicative of oesophageal dysfunction. Supra-aortic and infra-aortic oesophageal coronal diameters were measured in high-resolution CT. Oesophageal dilatation was deemed present when the diameters exceeded 10 mm. 19 patients (25%) had supra-aortic oesophageal dilatation and 48 patients (63.1%) had infra-aortic dilatation. The prevalence of radionuclide transit delay was 77.6%. All patients (19/19) with supra-aortic dilatation had oesophageal dysfunction, compared with 70.2% (40/57) of the patients with no supra-aortic dilatation (p = 0.004). Oesophageal dysfunction was present in 97.9% (47/48) of patients with infra-aortic dilatation, compared with 42.9% (12/28) in patients without it (p < 0.001). Receiver operating characteristic (ROC) curves have demonstrated that the supra-aortic and infra-aortic diameters had good discriminatory capacity for oesophageal dysfunction in systemic sclerosis (area under the curve, 95% confidence interval: 0.80, 0.70-0.89 and 0.92, 0.86-0.98, respectively). There is a clinically significant association between oesophageal dysmotility and high-resolution CT findings of oesophageal coronal dilatation. The evaluation of infra-aortic oesophageal coronal diameter can provide additional useful information about the functional and anatomic conditions of the oesophagus in systemic sclerosis.

Entities:  

Mesh:

Year:  2006        PMID: 16885178     DOI: 10.1259/bjr/17000205

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  12 in total

Review 1.  The role of high-resolution manometry in the assessment of upper gastrointestinal involvement in systemic sclerosis: a systematic review.

Authors:  Wouter Schutyser; Ludovic Cruyt; Jean-Baptiste Vulsteke; Jan L Lenaerts; Ellen De Langhe
Journal:  Clin Rheumatol       Date:  2019-11-11       Impact factor: 2.980

2.  Relationship between interstitial lung disease and oesophageal dilatation on chest high-resolution computed tomography in patients with systemic sclerosis: a cross-sectional study.

Authors:  Fausto Salaffi; Marco Di Carlo; Marina Carotti; Paolo Fraticelli; Armando Gabrielli; Andrea Giovagnoni
Journal:  Radiol Med       Date:  2018-04-23       Impact factor: 3.469

3.  Esophageal dilatation and interstitial lung disease in systemic sclerosis: A cross-sectional study.

Authors:  Carrie Richardson; Rishi Agrawal; Jungwha Lee; Orit Almagor; Ryan Nelson; John Varga; Michael J Cuttica; Jane D Amico Dematte; Rowland W Chang; Monique E Hinchcliff
Journal:  Semin Arthritis Rheum       Date:  2016-02-26       Impact factor: 5.532

4.  Comment on "Esophageal dilatation and interstitial lung disease in systemic sclerosis: A cross-sectional study".

Authors:  Aileen Hoffmann; Jungwha Lee; Madeleine Ma; Rishi Agrawal; Rowland W Chang; Carrie Richardson; Monique Hinchcliff; Kimberly Showalter
Journal:  Semin Arthritis Rheum       Date:  2016-05-06       Impact factor: 5.532

Review 5.  GI Manifestations With a Focus on the Esophagus: Recent Progress in Understanding Pathogenesis.

Authors:  Marie-Pier Tétreault; Peter Kahrilas
Journal:  Curr Rheumatol Rep       Date:  2019-07-03       Impact factor: 4.592

6.  Significance of various pulmonary and extrapulmonary abnormalities on HRCT of the chest in scleroderma lung.

Authors:  Anoop Kumar Pandey; Pearce Wilcox; Julie O' Brien; Jennifer Ellis; Jacquie Brown; Jonathon Leipsic
Journal:  Indian J Radiol Imaging       Date:  2013-10

7.  The Extrapulmonary Manifestations of Systemic Sclerosis on Chest High Resolution Computed Tomography.

Authors:  Donya Farrokh; Bita Abbasi; Yalda Fallah-Rastegar; Zahra Mirfeizi
Journal:  Tanaffos       Date:  2015

8.  The 5-HT1A receptor agonist buspirone improves esophageal motor function and symptoms in systemic sclerosis: a 4-week, open-label trial.

Authors:  George P Karamanolis; Stylianos Panopoulos; Konstantinos Denaxas; Anastasios Karlaftis; Alexandra Zorbala; Dimitrios Kamberoglou; Spiros D Ladas; Petros P Sfikakis
Journal:  Arthritis Res Ther       Date:  2016-09-01       Impact factor: 5.156

9.  Esophageal Dilation and Other Clinical Factors Associated With Pulmonary Function Decline in Patients With Systemic Sclerosis.

Authors:  Kimberly Showalter; Aileen Hoffmann; Carrie Richardson; David Aaby; Jungwha Lee; Jane Dematte; Rishi Agrawal; Hatice Savas; Xiaoping Wu; Rowland W Chang; Monique Hinchcliff
Journal:  J Rheumatol       Date:  2021-07-15       Impact factor: 4.666

Review 10.  Esophageal manifestation in patients with scleroderma.

Authors:  Theodoros A Voulgaris; Georgios P Karamanolis
Journal:  World J Clin Cases       Date:  2021-07-16       Impact factor: 1.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.